Clearmind Medicine Files Patent Application in India for Next-Gen Psychedelic Compounds to Treat Mental Health Disorders

Go back to Clearmind Medicine Files Patent Application in India for Next-Gen Psychedelic Compounds to Treat Mental Health Disorders
(NASDAQ: CMND) Delayed: 2.60 -0.08 (2.99%)
Previous Close $2.68    52 Week High
Open $2.64    52 Week Low
Day High $2.68    P/E N/A 
Day Low $2.60    EPS
Volume 19,171